LIANG Li. Interpretation on The Consensus Among Chinese Experts About Acquisition and Quality Control of Digital Pathological Images in Cervical Liquid Based Cytology[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 571-573. doi: 10.12290/xhyxzz.2022-0100
Citation:
LIANG Li. Interpretation on The Consensus Among Chinese Experts About Acquisition and Quality Control of Digital Pathological Images in Cervical Liquid Based Cytology[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 571-573. doi: 10.12290/xhyxzz.2022-0100
LIANG Li. Interpretation on The Consensus Among Chinese Experts About Acquisition and Quality Control of Digital Pathological Images in Cervical Liquid Based Cytology[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 571-573. doi: 10.12290/xhyxzz.2022-0100
Citation:
LIANG Li. Interpretation on The Consensus Among Chinese Experts About Acquisition and Quality Control of Digital Pathological Images in Cervical Liquid Based Cytology[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 571-573. doi: 10.12290/xhyxzz.2022-0100
Interpretation on The Consensus Among Chinese Experts About Acquisition and Quality Control of Digital Pathological Images in Cervical Liquid Based Cytology
In order to promote the establishment of standardized digital pathological image-database of cervical liquid-based cytology and the development and application of artificial intelligence-assisted diagnostic products, the first domestic expert consensus in the field of digital pathology namely The consensus among Chinese experts about acquisition and quality control of digital pathological images in cervical liquid-based cytology was published in 2021 and jointly formulated by the group of digital pathology and artificial intelligence of the Association of Chinese Pathologists, the Working Committee of Digital pathology and artificial intelligence of the pathological branch of the Chinese Medical Association, and the group of cell pathology of the Chinese Medical Association. Based on the key contents of the consensus, this paper interprets the relevant issues and looks forward to the future development.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68: 394-424. doi: 10.3322/caac.21492
Wang B, He M, Chao A, et al. Cervical cancer screening among adult women in China, 2010[J]. Oncologist, 2015, 20: 627-634. doi: 10.1634/theoncologist.2014-0303
[5]
Tang HP, Cai D, Kong YQ, et al. Cervical cytology screening facilitated by an artificial intelligence microscope: A preli-minary study[J]. Cancer Cytopathol, 2021, 129: 693-700. doi: 10.1002/cncy.22425
[6]
Bao H, Bi H, Zhang X, et al. Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study[J]. Gynecol Oncol, 2020, 159: 171-178.
[7]
Bao H, Sun X, Zhang Y, et al. The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women[J]. Cancer Med, 2020, 9: 6896-6906.
[8]
Zhu X, Li X, Ong K, et al. Hybrid AI-assistive diagnostic model permits rapid TBS classification of cervical liquid-based thin-layer cell smears[J]. Nat Commun, 2021, 12: 3541.